pyruvaldehyde has been researched along with scopoletin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WC; Cheng, AS; Liao, BC; Wu, JF; Wu, SC; Xu, KD | 1 |
1 other study(ies) available for pyruvaldehyde and scopoletin
| Article | Year |
|---|---|
Scopoletin protects against methylglyoxal-induced hyperglycemia and insulin resistance mediated by suppression of advanced glycation endproducts (AGEs) generation and anti-glycation.
Topics: Animals; Glycation End Products, Advanced; Hyperglycemia; Insulin Resistance; Male; Pyruvaldehyde; Rats; Rats, Wistar; Scopoletin | 2015 |